Selected Publications

Gysler SM, Drapkin R: Tumor innervation: peripheral nerves take control of the tumor microenvironment. J Clin Invest 131(11):e147276 : 2021.

Nasioudis D, Gysler S, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Ko EM: Prevalence of lymph node metastasis and role of lymphadenectomy for apparent early stage ovarian clear cell carcinoma. Poster Society of Gynecologic Oncology Annual meeting : 2021 *virtual.

Nasioudis D, Gysler S, Ko EM, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Latif NA: Do patients with FIGO stage II endometrioid endometrial carcinoma benefit from the addition of chemotherapy to adjuvant radiation therapy? Poster, Society of Gynecologic Oncology Annual meeting : 2021 *virtual.

Nasioudis D, Heyward Q, Gysler S, Giuntoli RL, Cory L, Kim S, Morgan MA, Haggerty AF, Ko EM, Latif NA: Is there a benefit of performing an omentectomy for clinical stage I high-grade endometrial carcinoma? Surg Oncol 37:101534 : 2021.

Latif NA, Gysler S, Haggerty AF, Giuntoli II RL, Ko EM, Cory L: Cytoreductive surgery for advanced-stage ovarian cancer with upper abdominal disease performed by gynecologic oncologists alone versus multiple surgical specialties: Is there a difference in outcomes? Poster, Society of Gynecologic Oncologist Annual Meeting : 2020 *virtual.

Oh JK, Nasioudis D, Gysler S, Ko EM, Morgan MA, Haggerty AF, Kim SK, Cory L, Latif NA: Use of adjuvant chemotherapy for early-stage low-grade serous ovarian carcinoma. Poster, Society of Gynecologic Oncologist Annual Meeting : 2020 *virtual.

Nasioudis D, Heyward Q, Gysler S, Giuntoli II RL, Cory L, Kim SH, Morgan MA, Haggerty AF, Ko EM, Latif NA: Is there a benefit of performing omentectomy for stage I high-grade endometrial cancer. Poster, Society of Gynecologic Oncology : 2020 *Virtual.

Heyward Q, Nasioudis D, Gysler S, Giuntoli II RL, Cory L, Kim SH, Morgan MA, Haggerty AF, Ko EM, Latif NA: Is there any utility in performing lymphadenectomy for early-stage mucinous ovarian carcinoma? Poster, Society of Gynecologic Oncologist Annual Meeting : 2020 * virtual.

Webster EM, Yadav GS, Gysler S, McNamara B, Black J, Tymon-Rosario J, Zeybek B, Han C, Arkfeld CK, Andikyan V, Menderes G, Huang G, Azodi M, Silasi DA, Santin AD, Schwartz PE, Ratner ES, Altwerger G: Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study. Gynecol Oncol Rep 34:100667 : 2020.

Pepin A, Chesnokova A, Pishko A, Gysler S, Martin C, Smith E, Kassick M, Taunk NK.: Hormone Replacement Therapy in Patients with Gynecologic Cancer and Radiation-Induced Premature Ovarian Insufficiency Int J Radiat Oncol Biol Phys : 2024.

Kader T, Lin JR, Hug CB, Coy S, Chen YA, de Bruijn I, Shih N, Jung E, Pelletier RJ, Lopez Leon M, Mingo G, Omran DK, Lee JS, Yapp C, Satravada BA, Kundra R, Xu Y, Chan S, Tefft JB, Muhlich JL, Kim SH, Gysler SM, Agudo J, Heath JR, Schultz N, Drescher CW, Sorger PK, Drapkin R, Santagata S.: Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma Cancer Discov : 2024.

Reavis HD, Gysler SM, McKenney GB, Knarr M, Lusk HJ, Rawat P, Rendulich HS, Mitchell MA, Berger DS, Moon JS, Ryu S, Mainigi M, Iwanicki MP, Hoon DS, Sanchez LM, Drapkin R: Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells. JCI Insight 9(5):e170961 : 2024.

Tubridy EA, Eiva MA, Liu F, Omran DK, Gysler S, Brown EG, Roy AG, Zeng Y, Oh J, Cao Q, Gitto SB, Powell DJ Jr: CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival. Gynecol Oncol 25(3):330-345 : 2024.

Menderes G, Lopez S, Han C, Altwerger G, Gysler S, Varughese J, Schwartz PE, Santin AD: Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it. Discov Med 26(141):39-50 : 2018.

Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE: Ten-Year Comparison Study of Type 1 and 2 Endometrial Cancers: Risk Factors and Outcomes. Gynecol Obstet Invest 84(3):290-297 : 2019.

Hui P, Gysler SM, Uduman M, Togun TA, Prado DE, Brambs CE, Nallur S, Schwartz PE, Rutherford TJ, Santin AD, Weidhaas JB, Ratner ES: MicroRNA signatures discriminate between uterine and ovarian serous carcinomas. Hum Pathol 76:133-140 : 2018.

Menderes G, Gysler SM, Vadivelu N, Silasi DA: Challenges of Robotic Gynecologic Surgery in Morbidly Obese Patients and How to Optimize Success. Curr Pain Headache Rep 23(7):51 : 2019.

Academic Contact Information

Division of Gynecologic Oncology
Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
10th Floor South Tower
Philadelphia, PA 19104
Patient appointments: 800-789-7366